| Ytd | -40.66% | |
| 1y | -58.50% |
| Open | 10.27 | Prev Close | 10.28 | Low | 9.99 | High | 10.27 | Mkt Cap | 623.19M |
| Vol | 1.69M | Avg Vol | 829.88K | EPS | 0.18 | P/E | 55.78 | Forward P/E | -25.76 |
| Beta | 0.64 | Short Ratio | 7.35 | Inst. Own | 104.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-02 | 50-d Avg | 11.18 | 200-d Avg | 11.91 | 1yr Est | 32.47 |
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's ProviderConnect audiences are now a
This added to lingering negative sentiment following the company's latest earnings release. Investor
DA Davidson analyst Clark Wright maintains Phreesia (NYSE:PHR) with a Buy and lowers the price ta
Baird analyst Joseph Vruwink maintains Phreesia (NYSE:PHR) with a Neutral and raises the price ta
Although its net income rose sharply, analysts expected better. On a brighter note, the company slig
https://www.sec.gov/Archives/edgar/data/1412408/000162828026060497/phreesia-sx3asr2026.htm
Phreesia Inc (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.
Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Anal
Wells Fargo analyst Stan Berenshteyn maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter e
Phreesia (PHR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Esti
Phreesia NYSE: PHR reported second-quarter fiscal 2027 revenue growth and continued profitability ex
Phreesia (NYSE:PHR) reported second-quarter financial results on Wednesday. The transcript from the
Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-mar
Phreesia (NYSE:PHR) affirms FY2027 sales outlook from $510.000 million-$520.000 million to $510.000
Phreesia (NYSE:PHR) reported quarterly earnings of $0.03 per share which missed the analyst consensu
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the
Deutsche Bank AG bought a new position in shares of Phreesia, Inc. (NYSE: PHR) in the second quarter
Phreesia (NYSE: PHR - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both sma
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Dimensional Fund Advisors LP lessened its holdings in Phreesia, Inc. (NYSE: PHR) by 22.9% in the und
Phreesia, Inc. (NYSE: PHR - Get Free Report)'s stock price gapped up before the market opened on Fri
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal second quarte
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investo
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investo
EUDA Health (NASDAQ: EUDA - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both sma
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia and March of Dimes announce a partner
On July 22, 2026, Phreesia Inc (PHR) shares fell 5.6% to a current price of $10.01. This decline com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
Truist Securities analyst Jailendra Singh maintains Phreesia (NYSE:PHR) with a Hold and raises th
Citigroup analyst Daniel Grosslight maintains Phreesia (NYSE:PHR) with a Neutral and raises the p
Canaccord Genuity analyst Richard Close maintains Phreesia (NYSE:PHR) with a Buy and lowers the p
SNOW: 38% | Snowflake shares are trading higher after the company reported better-than-expected Q1 f
Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Oth
Phreesia (NYSE:PHR) affirms FY2027 sales outlook from $510.000 million-$520.000 million to $510.000
Phreesia (NYSE:PHR) reported quarterly earnings of $0.05 per share which met the analyst consensus e
Wells Fargo analyst Stan Berenshteyn downgrades Phreesia (NYSE:PHR) from Overweight to Equal-Weig
Barclays analyst Glen Santangelo downgrades Phreesia (NYSE:PHR) from Overweight to Equal-Weight a
On May 7, 2026, Phreesia, Inc. (the "Company") implemented a restructuring plan intended to
Keybanc analyst Brandon Nispel maintains Phreesia (NYSE:PHR) with a Overweight and lowers the pri
Citigroup analyst Daniel Grosslight downgrades Phreesia (NYSE:PHR) from Buy to Neutral and lowers
JP Morgan analyst Alexei Gogolev downgrades Phreesia (NYSE:PHR) from Overweight to Neutral and lo
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
Truist Securities analyst Jailendra Singh downgrades Phreesia (NYSE:PHR) from Buy to Hold and low